Our laboratory demonstrated that arsenite-transformed malignant UROtsa cells exhibit characteristics of the basal muscle-invasive phenotype of bladder cancer, including high expression of basal markers such as EGFR, KRT1, KRT5, and KRT6 [10,23,24]. The gene discussed is KRT5; the disease is urinary bladder carcinoma.